Design, synthesis, inhibition studies, and molecular modeling of pepstatin analogues addressing different secreted aspartic proteinases of Candida albicans

被引:19
作者
Cadicamo, Cosimo D. [1 ]
Mortier, Jeremie [1 ,2 ]
Wolber, Gerhard [2 ]
Hell, Marie [1 ]
Heinrich, Ina E. [1 ]
Michel, Dana [1 ]
Semlin, Lydia [4 ]
Berger, Ursula [3 ]
Korting, Hans C. [2 ,4 ]
Hoeltje, Hans-Dieter
Koksch, Beate [1 ]
Borelli, Claudia [4 ]
机构
[1] Free Univ Berlin, Dept Organ Chem, D-14195 Berlin, Germany
[2] Free Univ Berlin, Dept Pharm, D-14195 Berlin, Germany
[3] Univ Munich, Dept Med Informat Biostat & Epidemiol IBE, D-81377 Munich, Germany
[4] Univ Munich, Dept Dermatol & Allergy, D-80337 Munich, Germany
关键词
Anti-virulence agent; Peptidomimetic; Candidapeptidase; Secreted aspartic proteinases inhibition; Pepstatin; Candida albicans; SOLID-PHASE SYNTHESIS; CRYSTAL-STRUCTURE; IN-VIVO; VIRULENCE; EXPRESSION; PROTEASES; PHARMACOPHORES; PARAPSILOSIS; PATHOGENESIS; REPOSITORY;
D O I
10.1016/j.bcp.2012.12.008
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The family of secreted aspartic proteinases is known as an important virulence factor of yeast infections by Candida albicans in particular, which is the most common fungal pathogen for humans with respect to systemic disease. Due to the continuing increase of drug resistant strains, these proteinases are currently considered as promising drug target candidates. Based on the known Sap2-substrate specificity data and X-ray analyses of Sap/inhibitor complexes, three libraries of inhibitors were designed and synthesized by modifying the structure of pepstatin A, a common non-selective aspartic proteinase inhibitor, at the P3, P2, or P2' position. These novel inhibitors showed high inhibitory potencies for the isoenzymes Sap1, Sap3, Sap5 and Sap6. Then, the affinity and selectivity of the peptide ligands were investigated by molecular modeling, highlighting new key structural information for the design of potent and selective anti-virulence agents targeting Candida albicans. (c) 2012 Elsevier Inc. All rights reserved.
引用
收藏
页码:881 / 887
页数:7
相关论文
共 39 条
[1]  
AbadZapatero C, 1996, PROTEIN SCI, V5, P640
[2]   Glycosylphosphatidylinositol-anchored proteases of Candida albicans target proteins necessary for both cellular processes and host-pathogen interactions [J].
Albrecht, A ;
Felk, A ;
Pichova, I ;
Naglik, JR ;
Schaller, M ;
de Groot, P ;
MacCallum, D ;
Odds, FC ;
Schäfer, W ;
Klis, F ;
Monod, M ;
Hube, B .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (02) :688-694
[3]   Comprehensive characterization of secreted aspartic proteases encoded by a virulence gene family in Candida albicans [J].
Aoki, Wataru ;
Kitahara, Nao ;
Miura, Natsuko ;
Morisaka, Hironobu ;
Yamamoto, Yoshihiro ;
Kuroda, Kouichi ;
Ueda, Mitsuyoshi .
JOURNAL OF BIOCHEMISTRY, 2011, 150 (04) :431-438
[4]   SOLID-PHASE SYNTHESIS OF A SOLUBLE PEPSTATIN DERIVATIVE SUITABLE FOR THERAPEUTIC USE [J].
AUSTEN, BM ;
FORD, TF ;
GRANT, DAW ;
HERMONTAYLOR, J .
BIOSCIENCE REPORTS, 1982, 2 (06) :427-432
[5]  
Borelli C, 2009, THESIS LUDWIG MAXIMI
[6]   X-ray structures of Sap 1 and Sap5:: Structural comparison of the secreted aspartic proteinases from Candida albicans [J].
Borelli, Claudia ;
Ruge, Elisabeth ;
Lee, Jung Hoon ;
Schaller, Martin ;
Vogelsang, Alexandra ;
Monod, Michel ;
Korting, Hans Christian ;
Huber, Robert ;
Maskos, Klaus .
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2008, 72 (04) :1308-1319
[7]   The crystal structure of the secreted aspartic proteinase 3 from Candida albicans and its complex with pepstatin A [J].
Borelli, Claudia ;
Ruge, Elisabeth ;
Schaller, Martin ;
Monod, Michel ;
Korting, Hans Christian ;
Huber, Robert ;
Maskos, Klaus .
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2007, 68 (03) :738-748
[8]  
Braga-Silva LA, 2011, CURR MED CHEM, V18, P2401
[9]   Investigation of the synthetic route to pepstatin analogues by SPPS using O-protected and O-unprotected statine as building blocks [J].
Cadicamo, Cosimo D. ;
Asante, Vivian ;
Abu Ammar, Morhaf ;
Borelli, Claudia ;
Korting, Hans C. ;
Koksch, Beate .
JOURNAL OF PEPTIDE SCIENCE, 2009, 15 (04) :272-277
[10]   Aspartic proteinases in disease: A structural perspective [J].
Cooper, JB .
CURRENT DRUG TARGETS, 2002, 3 (02) :155-173